ISPC Insider Trading

Insider Ownership Percentage: 12.20%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

iSpecimen Insider Trading History Chart

This chart shows the insider buying and selling history at iSpecimen by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

iSpecimen Share Price & Price History

Current Price: $0.49
Price Change: Price Increase of +0.0303 (6.65%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for ISPC up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

iSpecimen Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/14/2023Benjamin BielakInsiderBuy18,000$0.72$12,960.0084,348View SEC Filing Icon  
5/31/2023Tracy CurleyCEOBuy4,400$1.25$5,500.0049,541View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for iSpecimen (NASDAQ:ISPC)

13.62% of iSpecimen stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ISPC by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

iSpecimen Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/17/2025Scientech Research LLC29,488$38K0.0%N/A0.302%Search for SEC Filing on Google Icon
11/14/2025Virtu Financial LLC63,257$82K0.0%N/A0.647%Search for SEC Filing on Google Icon
2/17/2025Bridgeway Capital Management LLC21,800$58K0.0%N/A2.271%Search for SEC Filing on Google Icon
7/22/2022Grimes & Company Inc.62,014$0.14M0.0%+78.3%0.699%Search for SEC Filing on Google Icon
5/18/2022Teton Advisors Inc.40,000$0.22M0.0%N/A0.454%Search for SEC Filing on Google Icon
5/11/2022Bleichroeder LP65,834$0.67M0.1%-80.8%0.747%Search for SEC Filing on Google Icon
5/6/2022Grimes & Company Inc.34,771$0.19M0.0%N/A0.394%Search for SEC Filing on Google Icon
2/15/2022Kepos Capital LP190,000$1.48M0.1%-15.6%2.177%Search for SEC Filing on Google Icon
2/10/2022Bleichroeder LP342,180$2.83M0.4%-44.6%3.920%Search for SEC Filing on Google Icon
2/8/2022Main Street Financial Solutions LLC10,500$82K0.0%N/A0.120%Search for SEC Filing on Google Icon
11/16/2021Bleichroeder LP618,180$3.61M0.6%+3.0%8.835%Search for SEC Filing on Google Icon
11/9/2021BlackRock Inc.6,007$35K0.0%N/A0.086%Search for SEC Filing on Google Icon
10/27/2021Telemus Capital LLC24,400$0.14M0.0%N/A0.352%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
iSpecimen logo
iSpecimen Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Lexington, Massachusetts.
Read More on iSpecimen

Today's Range

Now: $0.49
Low: $0.45
High: $0.51

50 Day Range

MA: $0.75
Low: $0.42
High: $1.29

52 Week Range

Now: $0.49
Low: $0.39
High: $4.66

Volume

329,133 shs

Average Volume

427,200 shs

Market Capitalization

$4.75 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.8

Who are the major institutional investors of iSpecimen?

iSpecimen's top institutional shareholders include:
  1. Virtu Financial LLC — 0.65%
  2. Scientech Research LLC — 0.30%
Learn More about top institutional investors of iSpecimen stock.

Which major investors are buying iSpecimen stock?

Within the last quarter, ISPC stock was bought by institutional investors including:
  1. Virtu Financial LLC
  2. Scientech Research LLC